Indegene posts Q4 FY25 consolidated PAT at Rs. 117.6 Cr
29 Apr 2025 //
INDPHARMAPOST
Indegene launches new center in London
20 Mar 2025 //
INDPHARMAPOST
CliniOps, Indegene Partner to Accelerate Clinical Trials
09 Jan 2025 //
ACCESSWIRE
CliniOps Partners With Indegene To Boost Clinical Trial Speed
09 Jan 2025 //
GLOBENEWSWIRE
Indegene announces new Center in Hyderabad
20 Nov 2024 //
INDPHARMAPOST
Indegene still to resolve pending charge claim by former US employee
07 May 2024 //
BIOSPECTRUM ASIA
Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired
02 Apr 2024 //
GLOBENEWSWIRE
Indegene acquires Trilogy Writing & Consulting, a medical writing consultancy
27 Mar 2024 //
GLOBENEWSWIRE
Everest Group recognizes Indegene as a Leader in Life Sciences Digital Services
24 Jan 2024 //
GLOBENEWSWIRE
HFS Research recognizes Indegene as a Market Leader in the HFS Horizons
20 Nov 2023 //
GLOBENEWSWIRE
Life sciences leaders discuss the future of commercialization at Indegene Summit
14 Sep 2023 //
GLOBENEWSWIRE
Indegene expands partnership with ConTIPI Medical Ltd to manage pelvic organ
24 May 2023 //
GLOBENEWSWIRE
Indegene & SynPhNe join hands to bring relief to stroke & TBI victims worldwide
16 May 2023 //
GLOBENEWSWIRE
Everest Group recognizes Indegene as a Leader in its Life Sciences Sales
06 Apr 2023 //
GLOBENEWSWIRE